BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:volixibat readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of volixibat\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05050136-10898@assetmemo.bio
DTSTAMP:20261121T005629Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:volixibat: Phase 2 readout est. (NCT05050136)
DESCRIPTION:volixibat\, phase 2\, Primary Biliary Cholangitis.\nStudy: A St
 udy to Evaluate Efficacy and Safety of an Investigational Drug Named Volix
 ibat in Patients With Itching Caused by Primary Biliary Cholangitis\nEstim
 ated primary completion: January 2027. This is a ClinicalTrials.gov estima
 te\, not a confirmed readout date\, and it can move.\nDrug page: https://a
 ssetmemo.bio/drug/volixibat#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT05050136
URL:https://assetmemo.bio/drug/volixibat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
